Yesterday during our Members-Only Conference Call we discussed a lot of themes and trade ideas, but I wanted to highlight two charts that remain an issue for our bullish Equities thesis. [Read more…]
The S&P500 Is A Hot Mess
Some people actually think this world is just filled with rainbows and butterflies and stocks are always supposed to go up. I never understood that ignorance. Sometimes stocks go up, sometimes they go down and sometimes they go sideways for a while. It will take you less than 5 minutes of market history research to understand this very simple fact.
Of those 3, I would argue we are in the ‘sideways for a while’ category in U.S. Stocks, particularly the S&P500. [Read more…]
Measuring Breadth Since January 2018
From the desk of Tom Bruni @BruniCharting
My presentation at Chart Summit 2019 focused on market breadth and how we like to keep our process of looking at the subject pretty simple.
While that presentation covered a number of our methods of measuring the market’s internals, in this post I want to share some stats we pulled this weekend that help provide some valuable context around the market’s rally from the December 24th lows.
[Premium] Signs Of A Long-Term Bottom Emerge
In our “Free Chart of The Week” we posed the question whether or not we’ve seen the end of the Mid/Small-Cap decline and presented some compelling breadth and momentum data.
This post is going to outline all of the “big picture” evidence that’s currently available and explain why we think the foundation has been laid for stocks to carve out a long-term bottom. [Read more…]
Breadth Continues To Confirm New Price Lows
From the desk of Tom Bruni @BruniCharting
In this post I want to share two charts from the weekend update of our Market Internals workbook, both of which confirm the continued deterioration in breadth as US Stocks make new lows.
[Free Chart of The Week] A Different Take On The Pharmaceuticals Sector
Over the last three weeks Sun Pharmaceuticals has been doing its best Deutsche Bank impression, losing roughly a third of its value and trading at levels not seen since March 2013.
As the largest component of the Nifty Pharmaceuticals Index this performance has been a major drag on the index, however, equally-weighted charts can offer us a much better read of the sector’s health.
[Free Chart(s) of The Week] What Sector Breadth Is Signaling
From the desk of Tom Bruni @BruniCharting
We’ve been looking for breadth and momentum divergences to be confirmed both in the US and globally to mark the start of “the bottom” in equities as an asset class, so today I want to highlight the breadth of one sector which provides perspective on the current market environment.
[Premium] Sector Breadth Update
From the desk of Tom Bruni @BruniCharting
Momentum and breadth diverged slightly in the major indices and many global markets, leading to a short-term bounce that’s been sold into so far. Today I want to look at sector breadth to highlight the extent of the weakness under the surface and outline what we’re watching for if/when prices retest their late October, and potentially Q1 lows.